Vines Capital Management »

Altimmune shares owned by Vines Capital Management

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Vines Capital Management from 13F filings

Historical chart of Vines Capital Management investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Vines Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Vines Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $58k 19k 3.08

More positions owned by Vines Capital Management

Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Ishares Tr Msci Usa Mmentm (MTUM)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core 60/40 Balan (AOR)

View all positions for Vines Capital Management

Top funds holding Altimmune

BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Susquehanna International
Millennium Management
Geode Capital Management
Alyeska Investment Group
Two Sigma Investments
Nuveen
Goldman Sachs Group
Dimensional Fund Advisors
Citadel Advisors
Marshall Wace

View all funds holding Altimmune